Can You Have a Hair Transplant With Folliculitis Decalvans?

Sometimes a hair transplant can be discussed after folliculitis decalvans, but not while the disease is active. I first need a clear diagnosis, a quiet scalp over a meaningful period, dermatology control, usable donor hair, and a realistic goal.

Pustules, wet crusting, drainage, spreading redness, increasing pain, or a recent flare make surgery the wrong next step. A transplant can move hair into skin, but it cannot switch off a chronic scarring scalp disease. Active disease is a stop signal until the scalp has been reviewed and controlled by the right medical team.

Active inflammation changes the whole plan

Ordinary postoperative folliculitis is usually a short term irritation around follicles after surgery. Folliculitis decalvans is different. It is a chronic scarring condition where pustules, crust, tenderness, tufted hairs, and expanding bald patches can return in the same area again and again.

That difference matters because the problem is not only cosmetic. If the recipient skin is inflamed, graft survival may be weaker. If the donor area is inflamed or scarred, extraction may create more damage than benefit. My separate guide on folliculitis after a hair transplant deals with common bumps and pimples. This page is about a diagnosed or strongly suspected scarring scalp disease before surgery is planned.

The first answer is often not surgery. It is to pause, document the disease, treat it, and reassess after the scalp proves stability. Delaying an operation protects the patient more than planting grafts into skin that is still sending warning signals.

What does quiet disease need to mean?

Patients sometimes hear the word quiet and assume that means cleared for surgery. I use a stricter meaning. Quiet means no fresh pustules, no wet crusting, no drainage, no spreading redness, no increasing pain, and no recent flare pattern that suggests the disease is still moving.

I also need to know how long the scalp has stayed quiet. One good photograph or one settled week is not the same as a stable period over months. If antibiotics, isotretinoin, steroid treatment, biologic treatment, or other dermatology care was only just changed, the surface may look better before the deeper pattern is proven.

For that reason, I treat folliculitis decalvans closer to other scarring alopecias than to simple scalp irritation. My guide to scarring alopecia and lichen planopilaris explains the same surgical principle. Stability comes before density planning.

The history I need before surgery

Before I discuss a hairline, crown, or graft count, I need a clear disease history. I ask when the first patch appeared, where flares happen, what treatments have been used, how recently pustules returned, whether a swab or biopsy was done, and whether a dermatologist is still actively treating the scalp. When the diagnosis is unclear, a scalp biopsy before hair transplant may be more useful than another graft estimate.

Photos are useful, but they are not enough by themselves. I need to know the trend. A single quiet photo can hide repeated flares. A single angry photo can look worse than the current condition. The pattern over time is what protects the patient from a rushed decision.

If the patient has another immune or inflammatory diagnosis, I also connect this with the broader medical picture. In that setting, my guide to autoimmune disease and hair transplant planning can be relevant even when the exact diagnosis is different. The operation should fit the patient, not just the bald patch.

Density promises are risky in scarred scalp

Scarred scalp behaves differently from healthy recipient skin. Blood supply, skin thickness, inflammation history, and tissue stiffness can all affect how many grafts the area can safely accept. I do not promise normal density in a scarred or previously inflamed patch.

In some patients, the realistic plan is a small improvement. In others, a test area may be wiser before treating a larger patch. In some, surgery is not sensible because the disease is not stable enough or the donor area cannot afford the risk. The target is safer improvement, not forcing a full coverage promise into poor skin.

That is also why graft numbers cannot be copied from a standard hairline case. My guide on how surgeons calculate graft numbers explains the normal planning logic. With folliculitis decalvans, the skin diagnosis becomes part of the calculation.

I check the donor area just as carefully

Many patients focus only on the bald scarred area. I also study the donor zone carefully. If there are pustules, crusts, keloid tendencies, old extraction damage, or active inflammation in the donor area, FUE may create new problems while trying to solve the old one.

This is similar to the caution I use for acne keloidalis nuchae and FUE planning. The diagnosis is different, but the donor safety question is familiar. We must not treat the back of the scalp as an unlimited bank when the skin itself may react badly.

Donor reserve is especially important if the patient already had surgery elsewhere or has weak hair characteristics. The pages on the donor area and weak donor area planning are useful background because folliculitis decalvans can make an already limited plan even tighter.

Flare planning comes before surgery

A flare after surgery can threaten both comfort and result. Inflammation can confuse the healing picture, create pain or crusting, and make patients worry that every shed hair is a failed graft. The more important issue is that a flare may continue the same disease process that caused scarring before surgery.

This does not mean every patient with a past diagnosis is impossible to treat. It means the flare plan has to exist before surgery. The dermatologist and the surgical team need a clear route if pustules or crusting returns, which medicines can be used around the procedure, what photographs should be sent, and when local urgent care is needed.

A transplant is not a treatment for the disease. It is a reconstructive step considered only after the disease is controlled. If that distinction is unclear, the operation is being discussed too early.

A cautious case has a sequence

When surgery might be reasonable, I use the sequence in the visual below to protect the patient from wishful thinking. It is not a checklist exercise. If one step is weak, the later steps do not rescue the plan. A small test area may be more responsible than covering the whole scarred patch.